SYNTHESIS AND EVALUATION OF WATER-SOLUBLE DIMETHYLAMINOETHYL ETHERS OF METHOXSALEN FOR PROLIFERATIVE SKIN DISORDERS.

IF 0.1 Q4 CHEMISTRY, ORGANIC
Heterocyclic Letters Pub Date : 2018-08-01
Christophe D Guillon, Yi-Hua Jan, Natalie Foster, Mridula Choudhuri, Jaya Saxena, Thomas M Mariano, Diane E Heck, Jeffrey D Laskin, Ned D Heindel
{"title":"SYNTHESIS AND EVALUATION OF WATER-SOLUBLE DIMETHYLAMINOETHYL ETHERS OF METHOXSALEN FOR PROLIFERATIVE SKIN DISORDERS.","authors":"Christophe D Guillon, Yi-Hua Jan, Natalie Foster, Mridula Choudhuri, Jaya Saxena, Thomas M Mariano, Diane E Heck, Jeffrey D Laskin, Ned D Heindel","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The natural product 8-methoxypsoralen (methoxsalen or 8-MOP) in combination with long wavelength ultraviolet light (UVA, 320-400 nm), also referred to as PUVA therapy, is used for the treatment of cutaneous proliferative disorders including psoriasis, vitiligo and mycosis fungoides. The use of 8-MOP (<b>3</b>) is limited by its poor water solubility and there remains a need to develop more water-soluble psoralens to enhance bioavailability following oral administration of the drug. In the present studies a water-soluble dimethylaminoethyl ether analog of 8-MOP was synthesized and analyzed for biological activity. This analog, (8-[2-(N,N-dimethylamino)ethoxy]-psoralen hydrochloride (<b>1</b>) [or CAS name: 9-[2-(dimethylamino)ethoxy]-7<i>H</i>-furo[3,2-<i>g</i>][1]benzopyran-7-one, hydrochloride], was found to be significantly more active than <b>3</b> in keratinocyte growth inhibition assays (IC<sub>50</sub> = 12 nM and 130 nM for <b>1</b> and <b>3</b>, respectively). The partially reduced dihydro derivative of <b>1</b>, 8-[2-(N,N-dimethylamino)ethoxy]-4',5'-dihydropsoralen hydrochloride (<b>2</b>) [or CAS name: 9-[2-(dimethylamino)ethoxy]-2,3-dihydro-7<i>H</i>-furo[3,2-<i>g</i>][1]benzopyran-7-one, hydrochloride] and the partially reduced 4',5'-dihydro-8-methoxypsoralen (<b>4</b>) lacking the water-solubilizing side-chain were significantly less active. As inhibitors of keratinocyte growth they ranked as IC<sub>50</sub> = 13,000 nM and 70,000 nM for <b>2</b> and <b>4</b>, respectively, indicating that an unsaturated furan ring in the psoralen was required for maximal activity. Compound (<b>1</b>) was found to readily intercalate and damage DNA following UVA light treatment as determined by plasmid DNA nicking and unwinding experiments in neutral and alkaline agarose gels. Taken together, these data demonstrate that a water-soluble dimethylaminoethyl ether psoralen targets DNA, is highly active as a photosensitizer, and may be useful in the treatment of skin diseases involving abnormal keratinocyte proliferation.</p>","PeriodicalId":44091,"journal":{"name":"Heterocyclic Letters","volume":null,"pages":null},"PeriodicalIF":0.1000,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875182/pdf/nihms-1029725.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heterocyclic Letters","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, ORGANIC","Score":null,"Total":0}
引用次数: 0

Abstract

The natural product 8-methoxypsoralen (methoxsalen or 8-MOP) in combination with long wavelength ultraviolet light (UVA, 320-400 nm), also referred to as PUVA therapy, is used for the treatment of cutaneous proliferative disorders including psoriasis, vitiligo and mycosis fungoides. The use of 8-MOP (3) is limited by its poor water solubility and there remains a need to develop more water-soluble psoralens to enhance bioavailability following oral administration of the drug. In the present studies a water-soluble dimethylaminoethyl ether analog of 8-MOP was synthesized and analyzed for biological activity. This analog, (8-[2-(N,N-dimethylamino)ethoxy]-psoralen hydrochloride (1) [or CAS name: 9-[2-(dimethylamino)ethoxy]-7H-furo[3,2-g][1]benzopyran-7-one, hydrochloride], was found to be significantly more active than 3 in keratinocyte growth inhibition assays (IC50 = 12 nM and 130 nM for 1 and 3, respectively). The partially reduced dihydro derivative of 1, 8-[2-(N,N-dimethylamino)ethoxy]-4',5'-dihydropsoralen hydrochloride (2) [or CAS name: 9-[2-(dimethylamino)ethoxy]-2,3-dihydro-7H-furo[3,2-g][1]benzopyran-7-one, hydrochloride] and the partially reduced 4',5'-dihydro-8-methoxypsoralen (4) lacking the water-solubilizing side-chain were significantly less active. As inhibitors of keratinocyte growth they ranked as IC50 = 13,000 nM and 70,000 nM for 2 and 4, respectively, indicating that an unsaturated furan ring in the psoralen was required for maximal activity. Compound (1) was found to readily intercalate and damage DNA following UVA light treatment as determined by plasmid DNA nicking and unwinding experiments in neutral and alkaline agarose gels. Taken together, these data demonstrate that a water-soluble dimethylaminoethyl ether psoralen targets DNA, is highly active as a photosensitizer, and may be useful in the treatment of skin diseases involving abnormal keratinocyte proliferation.

Abstract Image

Abstract Image

甲氧沙林水溶性二甲基氨基乙基醚的合成与评估,用于治疗增生性皮肤病。
天然产品 8-甲氧基补骨脂素(methoxsalen 或 8-MOP)与长波紫外线(UVA,320-400 纳米)(也称为 PUVA 疗法)相结合,可用于治疗皮肤增生性疾病,包括银屑病、白癜风和真菌病。8-MOP (3) 的水溶性较差,限制了它的使用,因此仍有必要开发水溶性更强的补骨脂素,以提高口服药物的生物利用度。本研究合成了 8-MOP 的水溶性二甲基氨基乙基醚类似物,并对其生物活性进行了分析。在角朊细胞生长抑制实验中,发现这种类似物(8-[2-(N,N-二甲基氨基)乙氧基]-补骨脂素盐酸盐(1)[或 CAS 名称:9-[2-(二甲基氨基)乙氧基]-7H-呋喃并[3,2-g][1]苯并吡喃-7-酮,盐酸盐]的活性明显高于 3(1 和 3 的 IC50 分别为 12 nM 和 130 nM)。1 的部分还原二氢衍生物 8-[2-(N,N-二甲基氨基)乙氧基]-4',5'-二氢补骨脂素盐酸盐(2)[或 CAS 名称:9-[2-(二甲基氨基)乙氧基]-2,3-二氢-7H-呋喃并[3,2-g][1]苯并吡喃-7-酮盐酸盐]和部分还原的 4',5'-二氢-8-甲氧基补骨脂素(4)(缺少水溶性侧链)的活性明显较低。作为角朊细胞生长抑制剂,2 和 4 的 IC50 分别为 13,000 nM 和 70,000 nM,表明补骨脂素中的不饱和呋喃环是最大活性的必要条件。通过在中性和碱性琼脂糖凝胶中进行质粒 DNA 挑刺和解旋实验,发现化合物 (1) 在经过 UVA 光处理后很容易插层和损伤 DNA。总之,这些数据表明,水溶性二甲基氨基乙基醚补骨脂素以 DNA 为靶标,作为光敏剂具有很高的活性,可用于治疗涉及角质细胞异常增殖的皮肤病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Heterocyclic Letters
Heterocyclic Letters CHEMISTRY, ORGANIC-
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信